Table 4.

Correlation of anti-Hsp70 and anti-Hsp60 with symptom severities

Symptom Severity	No.	Anti-Hsp70 No. (%)				Anti-Hsp60 No. (%)
		1:10	1:20	1:40	1:80	1:10	1:20	1:40	1:80
Step1: intermittent	30	2 (6.7)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Step2: mild persistent	36	10 (27.8)	5 (13.9)	2 (5.6)	1 (2.8)	3 (8.3)	1 (2.8)	1 (2.8)	1 (2.8)
Step3&4 moderate & severe persistent**	29	20 (69.0)	14 (48.3)	11 (37.9)	8 27.6)	14 (48.3)	5 (17.2)	4 (14.0)	4 (14.0)
R value*		0.809	0.958	0.968	0.959	0.954	0.864	0.947	0.947
P value*		0.000	0.000	0.000	0.001	0.000	0.000	0.016	0.016

* The analyses of correlation of symptom severities with different dilutions of anti-Hsp70 and anti-Hsp60

**: there are two severe persistent patients with asthma